Biological API Drug Manufacturing Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

  • Report Code : 535279
  • Industry : Chemicals and Materials
  • Published On : Jan 2021
  • Pages : 102
  • Publisher : 99strategy
  • Format: CMI Insight PPT FormatCMI Insight PDF Format

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Biological API Drug Manufacturing market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Biological API Drug Manufacturing are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Biological API Drug Manufacturing market segmented into
In-House manufacturing
Contract manufacturing

Based on the end-use, the global Biological API Drug Manufacturing market classified into
Monoclonal Antibody (mAb) Therapies
Vaccines
Insulin Therapies
Interferon Therapies
Others

Based on geography, the global Biological API Drug Manufacturing market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Lonza
Boehringer Ingelheim BioXcellence
Celltrion
DSM
Samsung BioLogics
Fujifilm Diosynth Biotechnologies
Cytovance Biologics
AbbVie
Baxter
CEPiA Sanofi
GSK
Pfizer CentreOne
Sandoz
Vetter
Wuxi Biologics

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BIOLOGICAL API DRUG MANUFACTURING INDUSTRY
2.1 Summary about Biological API Drug Manufacturing Industry
2.2 Biological API Drug Manufacturing Market Trends
2.2.1 Biological API Drug Manufacturing Production & Consumption Trends
2.2.2 Biological API Drug Manufacturing Demand Structure Trends
2.3 Biological API Drug Manufacturing Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 In-House manufacturing
4.2.2 Contract manufacturing
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Monoclonal Antibody (mAb) Therapies
4.3.2 Vaccines
4.3.3 Insulin Therapies
4.3.4 Interferon Therapies
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 In-House manufacturing
5.2.2 Contract manufacturing
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Monoclonal Antibody (mAb) Therapies
5.3.2 Vaccines
5.3.3 Insulin Therapies
5.3.4 Interferon Therapies
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 In-House manufacturing
6.2.2 Contract manufacturing
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Monoclonal Antibody (mAb) Therapies
6.3.2 Vaccines
6.3.3 Insulin Therapies
6.3.4 Interferon Therapies
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 In-House manufacturing
7.2.2 Contract manufacturing
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Monoclonal Antibody (mAb) Therapies
7.3.2 Vaccines
7.3.3 Insulin Therapies
7.3.4 Interferon Therapies
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 In-House manufacturing
8.2.2 Contract manufacturing
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Monoclonal Antibody (mAb) Therapies
8.3.2 Vaccines
8.3.3 Insulin Therapies
8.3.4 Interferon Therapies
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 In-House manufacturing
9.2.2 Contract manufacturing
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Monoclonal Antibody (mAb) Therapies
9.3.2 Vaccines
9.3.3 Insulin Therapies
9.3.4 Interferon Therapies
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Lonza
10.1.2 Boehringer Ingelheim BioXcellence
10.1.3 Celltrion
10.1.4 DSM
10.1.5 Samsung BioLogics
10.1.6 Fujifilm Diosynth Biotechnologies
10.1.7 Cytovance Biologics
10.1.8 AbbVie
10.1.9 Baxter
10.1.10 CEPiA Sanofi
10.1.11 GSK
10.1.12 Pfizer CentreOne
10.1.13 Sandoz
10.1.14 Vetter
10.1.15 Wuxi Biologics
10.2 Biological API Drug Manufacturing Sales Date of Major Players (2017-2020e)
10.2.1 Lonza
10.2.2 Boehringer Ingelheim BioXcellence
10.2.3 Celltrion
10.2.4 DSM
10.2.5 Samsung BioLogics
10.2.6 Fujifilm Diosynth Biotechnologies
10.2.7 Cytovance Biologics
10.2.8 AbbVie
10.2.9 Baxter
10.2.10 CEPiA Sanofi
10.2.11 GSK
10.2.12 Pfizer CentreOne
10.2.13 Sandoz
10.2.14 Vetter
10.2.15 Wuxi Biologics
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Table
1.Table Biological API Drug Manufacturing Product Type Overview
2.Table Biological API Drug Manufacturing Product Type Market Share List
3.Table Biological API Drug Manufacturing Product Type of Major Players
4.Table Brief Introduction of Lonza
5.Table Brief Introduction of Boehringer Ingelheim BioXcellence
6.Table Brief Introduction of Celltrion
7.Table Brief Introduction of DSM
8.Table Brief Introduction of Samsung BioLogics
9.Table Brief Introduction of Fujifilm Diosynth Biotechnologies
10.Table Brief Introduction of Cytovance Biologics
11.Table Brief Introduction of AbbVie
12.Table Brief Introduction of Baxter
13.Table Brief Introduction of CEPiA Sanofi
14.Table Brief Introduction of GSK
15.Table Brief Introduction of Pfizer CentreOne
16.Table Brief Introduction of Sandoz
17.Table Brief Introduction of Vetter
18.Table Brief Introduction of Wuxi Biologics
19.Table Products & Services of Lonza
20.Table Products & Services of Boehringer Ingelheim BioXcellence
21.Table Products & Services of Celltrion
22.Table Products & Services of DSM
23.Table Products & Services of Samsung BioLogics
24.Table Products & Services of Fujifilm Diosynth Biotechnologies
25.Table Products & Services of Cytovance Biologics
26.Table Products & Services of AbbVie
27.Table Products & Services of Baxter
28.Table Products & Services of CEPiA Sanofi
29.Table Products & Services of GSK
30.Table Products & Services of Pfizer CentreOne
31.Table Products & Services of Sandoz
32.Table Products & Services of Vetter
33.Table Products & Services of Wuxi Biologics
34.Table Market Distribution of Major Players
35.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
36.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
37.Table Global Biological API Drug Manufacturing Market Forecast (Million USD) by Region 2021f-2026f
38.Table Global Biological API Drug Manufacturing Market Forecast (Million USD) Share by Region 2021f-2026f
39.Table Global Biological API Drug Manufacturing Market Forecast (Million USD) by Demand 2021f-2026f
40.Table Global Biological API Drug Manufacturing Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure
1.Figure Global Biological API Drug Manufacturing Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Biological API Drug Manufacturing Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Biological API Drug Manufacturing Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Biological API Drug Manufacturing Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Biological API Drug Manufacturing Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Biological API Drug Manufacturing Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Biological API Drug Manufacturing Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure In-House manufacturing Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Contract manufacturing Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Monoclonal Antibody (mAb) Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Insulin Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Interferon Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure In-House manufacturing Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Contract manufacturing Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Monoclonal Antibody (mAb) Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Insulin Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Interferon Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure In-House manufacturing Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Contract manufacturing Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Monoclonal Antibody (mAb) Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Insulin Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Interferon Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure In-House manufacturing Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Contract manufacturing Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Monoclonal Antibody (mAb) Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Insulin Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Interferon Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure In-House manufacturing Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Contract manufacturing Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Monoclonal Antibody (mAb) Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Insulin Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Interferon Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure In-House manufacturing Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Contract manufacturing Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure Monoclonal Antibody (mA

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (thousand ton / metric ton / cubic meter).
Market is segmented by:
  • Product Types
  • Applications
  • Technology
  • End-use Industries
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers and restraints
  • Regulatory scenario
  • Industry trend
  • Pestle analysis
  • Porter’s analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 1001 4th Ave, #3200 Seattle, WA 98154, U.S.

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2021 Worldwide Market Reports. All rights reserved